Literature DB >> 30523786

Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence.

Nai Yang Fu1, Bhupinder Pal2, Yunshun Chen3, Felicity C Jackling2, Michael Milevskiy2, François Vaillant2, Bianca D Capaldo2, Fusheng Guo4, Kevin H Liu2, Anne C Rios5, Nicholas Lim4, Andrew J Kueh6, David M Virshup4, Marco J Herold6, Haley O Tucker7, Gordon K Smyth8, Geoffrey J Lindeman9, Jane E Visvader10.   

Abstract

Long-lived quiescent mammary stem cells (MaSCs) are presumed to coordinate the dramatic expansion of ductal epithelium that occurs through the different phases of postnatal development, but little is known about the molecular regulators that underpin their activation. We show that ablation of the transcription factor Foxp1 in the mammary gland profoundly impairs ductal morphogenesis, resulting in a rudimentary tree throughout life. Foxp1-deficient glands were highly enriched for quiescent Tspan8hi MaSCs, which failed to become activated even in competitive transplantation assays, thus highlighting a cell-intrinsic defect. Foxp1 deletion also resulted in aberrant expression of basal genes in luminal cells, inferring a role in cell-fate decisions. Notably, Foxp1 was uncovered as a direct repressor of Tspan8 in basal cells, and deletion of Tspan8 rescued the defects in ductal morphogenesis elicited by Foxp1 loss. Thus, a single transcriptional regulator Foxp1 can control the exit of MaSCs from dormancy to orchestrate differentiation and development.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fox transcription factors; Foxp1; Lgr5; Tetraspanin; Tspan8; Wnt; mammary gland development; mammary stem cell; quiescence

Mesh:

Substances:

Year:  2018        PMID: 30523786     DOI: 10.1016/j.devcel.2018.10.001

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  5 in total

1.  CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.

Authors:  April C Watt; Paloma Cejas; Molly J DeCristo; Otto Metzger-Filho; Enid Y N Lam; Xintao Qiu; Haley BrinJones; Nikolas Kesten; Rhiannon Coulson; Alba Font-Tello; Klothilda Lim; Raga Vadhi; Veerle W Daniels; Joan Montero; Len Taing; Clifford A Meyer; Omer Gilan; Charles C Bell; Keegan D Korthauer; Claudia Giambartolomei; Bogdan Pasaniuc; Ji-Heui Seo; Matthew L Freedman; Cynthia Ma; Matthew J Ellis; Ian Krop; Eric Winer; Anthony Letai; Myles Brown; Mark A Dawson; Henry W Long; Jean J Zhao; Shom Goel
Journal:  Nat Cancer       Date:  2020-11-09

2.  Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.

Authors:  Jihang Luo; Puyu Liu; Leibo Wang; Yi Huang; Yuanyan Wang; Wenjing Geng; Duo Chen; Yuju Bai; Ze Yang
Journal:  BMC Cancer       Date:  2020-11-09       Impact factor: 4.430

3.  Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1.

Authors:  Qi Sun; Yufen Wang; Adam Officer; Brianna Pecknold; Garrett Lee; Olivier Harismendy; Jay S Desgrosellier
Journal:  NPJ Breast Cancer       Date:  2022-01-13

4.  TET2 directs mammary luminal cell differentiation and endocrine response.

Authors:  Mi Ran Kim; Meng-Ju Wu; Yingsheng Zhang; Jer-Yen Yang; Chun Ju Chang
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

5.  Single cell transcriptome atlas of mouse mammary epithelial cells across development.

Authors:  Bhupinder Pal; Yunshun Chen; Michael J G Milevskiy; Gordon K Smyth; Jane E Visvader; François Vaillant; Lexie Prokopuk; Caleb A Dawson; Bianca D Capaldo; Xiaoyu Song; Felicity Jackling; Paul Timpson; Geoffrey J Lindeman
Journal:  Breast Cancer Res       Date:  2021-06-29       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.